middle.news
Osteopore Accelerates Growth with $20M Funding and Strategic Stem Cell Partnerships
9:33am on Friday 31st of January, 2025 AEDT
•
Healthcare
Read Story
Osteopore Accelerates Growth with $20M Funding and Strategic Stem Cell Partnerships
9:33am on Friday 31st of January, 2025 AEDT
Key Points
27% year-over-year revenue growth in CY24 despite Q4 operational challenges
Collaboration agreements signed with RxCell and CytoMed to advance scaffold-based and MSC-powered regenerative therapies
Strategic investment in Regen SPV with leading regenerative medicine scientists
Exclusive distribution deals secured in Brazil and Singapore to expand craniofacial and orthopaedic product reach
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Osteopore (ASX:OSX)
OPEN ARTICLE